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As more US HIV surveillance programs routinely use late HIV diagnosis to monitor and characterize HIV testing patterns, there
is an increasing need to standardize how late HIV diagnosis is measured. In this study, we compared two measures of late HIV
diagnosis, one based on time between HIV and AIDS, the other based on initial CD4+ results. Using data from Washington’s
HIV/AIDS Reporting System, we used multivariate logistic regression to identify predictors of late HIV diagnosis. We also
conducted tests for trend to determine whether the proportion of cases diagnosed late has changed over time. Both measures
lead us to similar conclusions about late HIV diagnosis, suggesting that being male, older, foreign-born, or heterosexual increase
the likelihood of late HIV diagnosis. Our ﬁndings reaﬃrm the validity of a time-based deﬁnition of late HIV diagnosis, while at
the same time demonstrating the potential value of a lab-based measure.
1.Background
Approximately one in ﬁve people living with HIV in the
United States is unaware of their HIV status [1]. Research
suggests that many of these individuals—at least a quarter of
a million people—regularly receive health care services, yet
they are not tested for HIV [2]. These missed opportunities
are costly, preventing early detection of HIV infection and
prolonging the HIV epidemic within our nation [3]. The
National HIV/AIDS Strategy includes a goal to reduce
HIV infections by increasing the proportion of infected
individuals who know their status, from an estimated 79%
to 90% by 2015 [4]. Accomplishing this goal will require
a substantial increase in HIV testing. Moreover, prevention
programs will need better ways to identify and characterize
people who are at risk for HIV but who are not routinely
tested for HIV.
Routine HIV screening, which leads to early diagnosis, is
an eﬃcacious and cost-eﬀective strategy for HIV prevention
[5–7]. Early diagnosis of HIV infection can reduce the costs
of HIV treatment, improve health outcomes, and prevent
others from becoming exposed to the virus [8–11]. Since
2006, the U.S. Centers for Disease Control and Prevention
(CDC) have recommended that all adult and adolescent
patients in health care settings be regularly screened for HIV,
regardless of known risk behaviors [2]. Similar recommen-
dations have been issued by the World Health Organization
and by the American College of Physicians [12]. Patients
and health care providers are encouraged to consider routine
HIV screening as a standard medical practice, similar to
screenings performed for other chronic health conditions,
such as cancer and cardiovascular disease.
A growing number of US HIV surveillance programs are
routinely monitoring late HIV diagnosis, or the proportion
of new HIV cases that are diagnosed late in the course of
theirHIVillness.LateHIVdiagnosisisameasureofprogram
performance within the Washington State Department of
Health’s HIV Prevention Program and is currently one of
three HIV-related metrics which are being used by CDC’s
Winnable Battles eﬀortto monitor and support state-speciﬁc
progress towards curbing the HIV epidemic [13]. Surveil-
lance data describing late HIV diagnosis provide a measure
of HIV testing frequency and help characterize HIV-infected
people who are unaware of their HIV status. Yet, there is
currently a lack of consensus regarding how late diagnosis
should be measured. More than 20 diﬀerent measures of late2 AIDS Research and Treatment
diagnosis have been cited in various publications [14]. In
2009, the European Late Presenter Consensus working group
established a harmonized deﬁnition of late HIV diagnosis
[15]. However, in the US, a standard deﬁnition has yet to
be adopted. Most surveillance programs use a time-based
approach in which newly diagnosed HIV cases deﬁned as
late are individuals diagnosed with AIDS within a short-time
period after initial diagnosis of HIV infection, for example
one month [16], three months [17], twelve months [18–20],
or even 3 years [21]. However, this approach can require
a lengthy follow-up period and hinges on our somewhat
limited ability to determine when a diagnosis ﬁrst occurred.
Also, the chosen time interval between diagnosis of HIV and
AIDS often varies across jurisdictions. The inconsistencies
in deﬁning late HIV diagnosis make examination of factors
associated with late diagnosis diﬃcult [17].
Outside the United States, surveillance programs com-
monly use initial CD4+ T-cell count to determine a patient’s
stage of HIV illness at the time of diagnosis [22]. This
approach is not dependent on long-term follow-up and
could provide a more reliable and comparable deﬁnition for
late diagnosis of HIV infection. Yet, while the completeness
of laboratory data has improved over time, many US
jurisdictions remain wary of potential bias associated with
the incomplete reporting of laboratory results [17]. This is
also a concern in Washington state, where comprehensive
HIV laboratory reporting has only been in place since 2006.
We designed this study with three objectives in mind.
First, we wish to inform state and local HIV prevention
eﬀorts by characterizing people with HIV who are diagnosed
late in the course of their HIV illness. Second, we wish
to determine whether the proportion of new HIV cases
diagnosed late has changed over the past decade. Third, we
compare two alternative measures of late HIV diagnosis,
evaluating whether these measures lead us to similar or
diﬀerent conclusions about late HIV diagnosis in our state,
and whether stated concerns about bias associated with
either measure are justiﬁed.
2. Methods
We used surveillance data from Washington state’s core
HIV/AIDS reporting system (eHARS). This data system
containsinformationaboutallindividualswhohavereceived
a conﬁdential diagnosis of HIV or AIDS while residing
in Washington. The state also maintains a comprehensive
laboratory reporting system which can be linked to eHARS
and which contains all reported CD4+ T-cell test results
associated with each HIV/AIDS case.
We analyzed adult cases, ages 18 years and older, who
were diagnosed with HIV infection while residing in Wash-
ingtonstatebetween2000and2009.Thetime-basedmeasure
deﬁnes a case as late if the individual is diagnosed with AIDS
within 12 months of initial HIV diagnosis. In our analysis of
the time-based measure, we excluded cases with incomplete
or missing dates of HIV or AIDS diagnosis (missing either
month or year). When calculating the time-based measure,
we also excluded cases diagnosed with HIV in 2009, since
reporting delayswouldpreventusfrombeing abletoidentify
all cases that received an AIDS diagnosis within the 12-
month follow-up period. The lab-based measure deﬁnes
cases as late if the initial CD4+ T-cell count is <350cells/mL,
basedoncurrentWHOrecommendationsforHIVtreatment
initiation. We excluded cases from our analysis if the initial
lab result was based on a specimen collected ≥90 days after
HIV diagnosis.
We used SAS software (version 9.2) to generate descrip-
tive statistics and conduct logistic regression, with relative
likelihood for late HIV diagnosis described using adjusted
odds ratios. Covariates in the multivariate regression model
included gender, age at HIV diagnosis, race and Hispanic
ethnicity, mode of HIV exposure, county of residence (at
diagnosis), and foreign-born status.
To test for trends over time, we used a JoinPoint
regression program (version 3.0) developed by the National
Cancer Institute. Slope was calculated based on the model
ln(y) = xb. Standard error of the dependent variable was
based on the assumption that the underlying data ﬁt a
Poissondistribution.Annualpercentchange(APC)wasused
to describe change in the proportion of cases diagnosed late
over time. APC assumes that rate of change occurs as a
constant percentage over a deﬁned time period.
3. Results
Among the 5,639 new HIV cases in Washington state
between 2000 and 2009, 91% had adequate data to calculate
a time-based measure of late HIV diagnosis (Table 1). All
but one of the cases with incomplete data were diagnosed
in 2009, which was too recent to determine whether an
AIDS diagnosis took place during the 12-month follow-up
period. Over the same time period, 71% of new cases had
documentation of a valid CD4+ T-cell test result within 90
daysofHIVdiagnosis.Whiletheproportionofcaseswithout
aC D 4 + T-cell laboratory result was relatively high (29%), it
appeared to decrease over time, from 35% in 2000 to only
17% in 2009. Regardless of measure, cases with complete
data generally resembled those with missing or incomplete
data. There were no statistical diﬀerences by gender or
race/ethnicity.However,wedidobservesmallbutstatistically
signiﬁcant diﬀerences with respect to age at HIV diagnosis,
mode of HIV exposure, and county of residence (lab-based
measure only).
Overall, a lower proportion of new HIV cases was diag-
nosed late using the time-based measure (37%) compared
with the lab-based measure (56%; Table 2). However, within
demographic and risk strata, the adjusted odds of being a
late HIV diagnosis were similar regardless of measure. Men
in our sample had 1.9–2.5 times the odds of being diagnosed
late compared to women. We also found strong evidence for
a positive association between late diagnosis and increasing
age at HIV diagnosis. For example, older adults (ages 45 and
older) had 1.8–2.2 times greater odds of being diagnosed
late than did adults in their late twenties and early thirties.
New HIV cases reporting heterosexual exposure had more
than twice the odds of late diagnosis compared to thoseAIDS Research and Treatment 3
Table 1: Comparing cases meeting two deﬁnitions of late HIV diagnosis, 2000–2009.
Lab-based measure of late diagnosis Time-based measure of late diagnosis
Late Not late Missing Total
No. (% of total) No. (% of total) No. (% of total) No. (% of total)
Late 1575 (28) 432 (8) 236 (4) 2243 (40)
Not late 113 (2) 1450 (26) 209 (4) 1772 (31)
Missing 216 (4) 1317 (23) 91 (2) 1624 (29)
Total 1904 (34) 3199 (57) 536 (10) 5639 (100)
Table 2: Characteristics of late HIV diagnoses, including adjusted∗ odds ratios, Washington state, 2000–2009.
Time-based late measure Lab-based late measure
2000–2008 2000–2009
(Late = AIDS within 12 months) (Late = CD4+ T-cell < 350 cells/mL)
No. % Late Odds ratio (95% CI)∗ No. % Late Odds ratio (95% CI)∗
Total late HIV diagnoses 1904 37% n/a n/a 2243 56% n/a n/a
Gender
Male 1622 38% 1.88 (1.53–2.31) 1905 56% 2.54 (1.98–3.25)
Female 282 36% Reference 338 54% Reference
Race/ethnicity
White, NH 1077 34% Reference 1273 51% Reference
Black, NH 382 42% 1.20 (1.01–1.43) 423 61% 1.21 (0.98–1.48)
Hispanic 273 43% 1.33 (1.07–1.65) 348 66% 1.61 (1.26–2.05)
Asian 80 44% 1.35 (0.95–1.90) 102 65% 1.34 (0.92–1.95)
NHOPI∗∗ 11 46% 1.68 (0.71–3.95) 11 55% 1.08 (0.43–2.71)
AI/AN 45 48% 1.68 (1.09–2.60) 44 67% 1.94 (1.13–3.34)
Multiple/unknown 36 39% 1.45 (0.93–2.28) 42 61% 1.72 (1.03–2.87)
Age at HIV diagnosis
18–25 yrs 91 16% 0.42 (0.33–0.54) 150 38% 0.57 (0.45–0.72)
25–34 yrs 479 30% Reference 601 51% Reference
35–44 yrs 753 41% 1.59 (1.38–1.83) 847 59% 1.38 (1.18–1.62)
45 yrs and over 581 50% 2.18 (1.85–2.57) 645 65% 1.82 (1.51–2.18)
Mode of HIV exposure
MSM 971 33% Reference 1202 52% Reference
IDU 179 42% 1.44 (1.15–1.81) 160 57% 1.41 (1.07–1.87)
MSM/IDU 97 25% 0.72 (0.56–0.92) 119 41% 0.67 (0.52–0.86)
Heterosexual 284 44% 1.92 (1.53–2.41) 318 57% 2.51 (1.90–3.32)
Blood/pediatric 7 50% 2.23 (0.75–6.58) 7 64% 1.85 (0.56–6.12)
NIR 366 51% 2.04 (1.67–2.48) 437 71% 2.62 (2.06–3.34)
Residence at HIV diagnosis
Inside King county 1049 34% Reference 1298 53% Reference
Outside King county 855 42% 1.36 (1.20–1.53) 945 61% 1.37 (1.19–1.58)
Country of origin
US-born 1352 35% Reference 1567 52% Reference
Foreign-born 552 46% 1.26 (1.06–1.51) 676 67% 1.34 (1.09–1.64)
∗Adjusting for gender, race/ethnicity, risk category, age at HIV diagnosis, residence in King County, and foreign-born status.
∗∗Native Hawaiian or other Paciﬁc Islander.
c a t e g o r i z e da sm e nw h oh a v es e xw i t hm e n( M S M ) .N o n -
MSM male cases, including those with no identiﬁed risk
category, actually had among the highest proportions of
late diagnoses: 54% and 75% according to the time-based
and lab-based measures, respectively. Cases residing outside
King County at the time of HIV diagnosis had odds of late
diagnosisthatwerenearly1.4timeslargerthancasesresiding
inside King County.
Foreign-born status was strongly associated with late
HIV diagnosis. Overall, the odds of late diagnosis were4 AIDS Research and Treatment
Table 3: Late HIV diagnoses by race/ethnicity and foreign-born status, Washington State, 2000–2009.
Time-based late measure Lab-based late measure
2000–2008 2000–2009
(Late = AIDS within 12 months of HIV) (Late = initial CD4 < 350)
No. % Late Odds ratio (95% CI)∗ No. % Late Odds ratio (95% CI)∗
US-born
White, NH 1011 34% Reference 1190 51% Reference
Black, NH 196 37% 1.07 (0.87–1.31) 203 55% 1.09 (0.86–1.38)
Hispanic 58 30% 0.98 (0.70–1.37) 83 57% 1.51 (1.06–2.16)
Asian 12 39% 1.59 (0.75–3.39) 15 54% 1.34 (0.62–2.88)
NHOPI∗∗ 3 30% 1.10 (0.27–4.42) 3 38% 0.69 (0.16–2.98)
AI/AN 43 49% 1.67 (1.06–2.61) 40 65% 1.68 (0.96–2.93)
Multiple/unknown 29 37% 1.35 (0.82–2.21) 33 58% 1.65 (0.95–2.86)
Foreign-born
White, NH 66 31% Reference 83 53% Reference
Black, NH 186 49% 2.16 (1.42–3.30) 220 69% 1.76 (1.08–2.88)
Hispanic 215 48% 2.33 (1.61–3.37) 265 70% 2.16 (1.43–3.27)
Asian 68 46% 2.03 (1.28–3.22) 87 67% 1.72 (1.03–2.88)
NHOPI 8 43% 3.41 (1.08–10.8) 8 67% 2.11 (0.58–7.65)
AI/AN 2 33% 1.68 (0.29–9.85) 4 100% n/a
Multiple/unknown 7 54% 3.13 (0.96–10.2) 9 75% 2.48 (0.61–10.1)
∗Adjusting for gender, risk category, age at HIV diagnosis, and residence in King County.
∗∗Native Hawaiian or other Paciﬁc Islander.
about 1.3 times greater among cases born outside the
United States versus those born within. However, foreign-
born status seemed to confound the association between
race/ethnicity and late HIV diagnosis (Table 3). Among
cases born in the US, there was generally little evidence
to suggest an association between race/ethnicity and late
HIV diagnosis. The odds of late diagnosis among US-
born American Indians and Alaska Natives (AI/AN) were
about 1.7 times larger than those among US-born whites.
Using the lab-based measure, US-born Hispanics had 1.5
times greater odds of late diagnosis compared to their
white counterparts. However, the time-based measure pro-
vided no evidence for such an association. Among cases
born outside the US, diﬀerences in the odds of late
diagnosis were much greater between racial/ethnic groups.
Among foreign-born cases, nonwhite cases had 1.7–3.4
times greater odds of late diagnosis compared to white
cases.
Statewide, there is some evidence to suggest that the
occurrence of late HIV diagnosis has decreased over the
pastdecade(Figure 1).JoinPointregressionofbothmeasures
showed an average decrease of about 2 percent per year.
However, only the slope associated with the lab-based
measure (APC = −2.00) was statistically signiﬁcant at the
P = 0.05 level. Most of the change appears to be explained by
signiﬁcant decreases in late diagnosis among US-born cases
(APC = −2.53), which comprise roughly 75% of all new HIV
cases in Washington (Figure 2). The proportion of new HIV
cases that are foreign-born has steadily risen over the past
decade.
4. Discussion
As our state’s HIV epidemic nears the end of its third
decade, the proportion of new HIV cases which are
diagnosed late remains unacceptably high. Although CDC
recommendations for the expansion of HIV testing have
been in place for more than ﬁve years, a substantial propor-
tion of new cases is still being detected late in the course of
their HIV illness, after the point at which treatment should
have been initiated. Statewide, declines in late HIV diagnosis
over the past ten years appear to be minimal. Indeed, our
ﬁndings support the notion that targeted HIV testing eﬀorts,
which depend heavily on patient and provider perceptions
of HIV risk, cannot by themselves reduce the number of
HIV-infected people who are infected but unaware of their
status [3, 23]. Many of the characteristics we observed
to be associated with late HIV diagnosis, such as being
heterosexual, or residing in a rural area, are not traditionally
considered strong indicators of HIV risk. Therefore, HIV
testing eﬀorts need to be broadened to include people who
a r ea te l e v a t e dr i s kf o rH I Vb u tw h oa r e ,f o rav a r i e t yo f
reasons, not getting tested.
Men in our sample were more likely to be diagnosed
late than women. This ﬁnding is consistent with several
published studies [24–26]. However, other attempts to char-
acterize the association between gender and late diagnosis
have proven inconclusive [18, 27]. Using either measure of
late diagnosis, the diﬀerence in the proportions of male and
female cases that were diagnosed late was relatively small
(<2%), suggesting the direction of the gender associationAIDS Research and Treatment 5
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Figure 1: New HIV diagnoses and proportions that were diagnosed
late, by year of HIV diagnosis, Washington State, 2000–2009.
Year of HIV diagnosis
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
30
40
50
60
70
80
90
100
P
e
r
c
e
n
t
l
a
t
e
(
%
)
Foreign-born
US-born
Figure 2: Trends in late HIV diagnosis (lab-based) and foreign-
born status, Washington State, 2000–2009.
could be sensitive to relatively minor diﬀerences in testing
patterns.Asreportedelsewhere,weobservedmenwithmode
of transmission categorized as MSM or MSM/IDU to be
among the least likely to be a late HIV diagnosis [28]. These
cases comprise the majority of HIV cases in Washington
state. However, since these risk categories do not by deﬁni-
tion contain female cases, they were eﬀectively ignored by
our multivariate regression model, with gender comparisons
and resulting odds ratios limited mainly to cases falling into
three risk categories: heterosexuals, injection drug users, and
cases with no identiﬁed risk factors.
Although women are generally less likely to perceive
themselves as being at risk for HIV, which would seem
to favor late diagnosis, they typically demonstrate higher
utilization of health services compared to men, and HIV
testing is more widely accessible to women as result of both
prenatal HIV screening as well as cervical cancer screening
[29, 30]. On the other hand, the association between gender
and late diagnosis could also be inﬂuenced by lower levels of
HIV testing within certain male subgroups, some of whom
mayactuallybeMSMbuthavenotbeenreportedassuch.For
example, research suggests that male Latinos at risk for HIV
tend to get tested for HIV less frequently, and often do not
identify as being gay or bisexual despite engaging in MSM
behaviors [31–35].
We expected a positive correlation between increasing
age and late diagnosis. The very act of delaying testing
requires the passage of time, and as time passes, people get
older. Also, as the body ages, CD4+ T-cell counts tend to
naturally decrease [36]. This results in a less-eﬀective speciﬁc
immune response, leading to greater viremia and less time to
AIDS among individuals who seroconvert [37, 38]. Finally,
some research indicates that older MSM test less often than
younger MSM [39].
Overall, we expected a stronger relationship between
race/ethnicity and late diagnosis than we observed, given the
widely documented lower testing rates among racial/ethnic
minorities [16, 21]. While crude associations were apparent,
racial/ethnic diﬀerences in late diagnosis were substantially
smaller once we controlled for foreign-born status. The
increased risk for late diagnosis among Native Americans
is consistent with other evidence showing higher levels of
poverty and limited access to health services within this
population [40]. Likewise, late diagnosis among Hispanics
could be due to barriers to HIV testing, particularly stigma-
inducedfearoftestingpositiveanddiﬃcultycommunicating
with providers among individuals who do not speak English
[41, 42].
Our ﬁnding that foreign-born status confounds the
associations between race/ethnicity and late HIV diagnosis is
consistent with other published ﬁndings [2, 18, 43]. While
foreign-born cases are more likely than US-born cases to
be diagnosed late, it is diﬃcult to determine how much of
this increased likelihood is due to lower HIV testing versus
other reasons. As result of strict HIV surveillance reporting
requirements in the US, some foreign-born cases could be
diagnosed outside the US but lack required documentation
to demonstrate that a previous diagnosis took place. This
could result in misclassiﬁcation bias, causing some foreign-
born cases to appear as late diagnoses when they really are
not. Needs assessments data have suggested that as many
as one quarter of foreign-born HIV cases diagnosed in our
state were actually diagnosed at least one year earlier than
the reported date of HIV diagnosis [32, 44]. Yet, diﬀerences
in testing behaviors could also be explained by other factors
associated with recent immigration to the US, such as
poor access to HIV testing services, language barriers, social
isolation, ﬁnancial instability, or lack of knowledge about
HIV [16, 27, 45].
4.1. Data Completeness and Limitations. Diﬀerences between
cases with and without supporting data were relatively small
and similar between late measures. The similarity in ﬁndings
suggests that both measures would be prone to the same
kinds of minimal bias.
The completeness of data supporting the time-based
measure is higher than that of the lab-based measure in our
study. However, this is heavily dependent on the duration of
the chosen observation period. Had we evaluated late HIV
diagnosis over a ﬁve-year time period, completeness would
have been lower for the time-based deﬁnition.6 AIDS Research and Treatment
Although we tend to assume that people with AIDS
have serious health conditions that compel them to seek
treatment, not all cases who develop AIDS seek care in
a timely manner. Thus we may have misclassiﬁed some
cases categorized as “not late” because although they have
progressed to AIDS, they have not yet been linked to care or
reported to our surveillance system. The time-based measure
is also a subject to reporting delays associated with the
diagnosis of HIV and AIDS, as well as our ability to monitor
diagnoses that take place either out-of-state or outside the
country.
Completeness of the data for the lab-based measure
is strongly dependent on whether a given jurisdiction has
implemented comprehensive lab reporting. Nevertheless, we
are aware that a growing proportion of providers in our state
are using out-of-state labs to process HIV-related specimens.
Laws governing the reporting of laboratory results vary by
state [46]. Although Washington has laws intended to ensure
thecomprehensivereportingofallHIVandAIDStestresults,
these laws do not apply to laboratories located outside state
borders. Hence, many CD4+ T-cell results likely remain
unreported each year, especially if they do not correspond to
an HIV or AIDS case deﬁnition, such as CD4+ T-cell counts
over 200.
The logistic regression models were based on cross-
sectional comparisons and do not indicate whether testing
patterns have changed over time. Cases with complete data
necessary to calculate either measure of lateness might not
be representative of all new HIV cases, resulting in selection
bias. Moderate case counts resulted in lower stratiﬁed cell
sizes and wider conﬁdence intervals that prevented our
ability to detect trends in late diagnosis within stratiﬁed sub-
groups.
The adjusted odds ratios generated by our logistic
regression model provide an indication of which variables
are associated with late HIV diagnosis in our state, as well
as some idea as to relative strength of those associations.
However, since late HIV diagnosis is a common event within
our sample, the odds ratios likely represent a substantial
overestimation of corresponding relative risks.
AmongnewHIVcasescategorizedasforeign-borninour
analysis, approximately 20% are missing information about
countryofbirth.Althoughsomeofthesecasesmightactually
have been born in the US, we do not consider this to be
a large limitation. By misclassifying some native-born cases
as foreign-born, we would essentially dilute the latter group,
making them appear more like native-born cases than they
actuallyare.Accurateclassiﬁcationofthesecaseswouldlikely
result in better separation between native and foreign-born
cases, which would likely improve our ability to measure an
association and strengthen our ﬁndings.
4.2. Strengths and Future Implications. To our knowledge,
this is the ﬁrst study which uses HIV surveillance data to
compare two measures of late HIV diagnosis. Our results
indicate that both measures point to the same risk factors
for late HIV diagnosis. The relative strength and direction of
these associations were also very similar.
Thelab-basedmeasureismoreclinicallyrelevantbecause
it is based on the current recommendations for treatment
initiation and can be easily modiﬁed as the standard of care
evolves. In addition, it allows the inclusion of at least one
additional year of data (the most recent). As our laboratory
reporting system matures, and with the expected intro-
duction of health information exchanges, the quality and
completeness of laboratory data should continue to improve
over time [47]. Among the 536 cases with missing data
needed to calculate the time-based measure, nearly half were
identiﬁed as late using the lab-based measure. On the other
hand, using both measures together could provide a broader
and potentially more informative understanding of late diag-
nosis, oﬀering additional information about cases that lack
adequate data to support either one measure or the other.
Strengths of our study include the use of nine years of
statewide surveillance data as well as an evaluation of two
diﬀerent ways of measuring late HIV diagnosis. Also, our
use of multiple logistic regression allowed us to control for
numerous potential confounders. Our results reaﬃrm the
validity of a time-based deﬁnition of late HIV diagnosis,
while at the same time demonstrating the potential value of a
lab-based measure. Moreover, because it is a subject to fewer
potentiallimitations,thelab-basedmeasuremightbeabetter
alternative in jurisdictions with comprehensive laboratory
reporting.
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